Axcelead Drug Discovery Partners, Inc. will combine scientific excellence, world-class IP protection and state-of-the art GLP accredited facilities and capabilities to deliver integrated end-to-end early discovery.
Axcelead is Japan's first provider of integrated drug discovery services - a one stop-shop for Research providing:
- Integrated drug-discovery aligned to delivering tangible innovative outcomes to clients
- Fee-for-service and FTE-based offerings to flexibility accessing drug-discovery expertise and technologies
- advisory support
Axcelead is the first comprehensive integrated drug discovery solutions provider in the pharmaceutical industry in Japan, having succeeded some portion of the drug discovery research department of Takeda Pharmaceutical Company Limited. and started its business in July 1, 2017.
An interview with our CEO was posted
on the PHARMA JAPAN
JIHO,Inc one of the most famous newspaper company in the pharmaceutical industry in Japan interviewed Yoshinori Ikeura, our CEO, on future prospective of small-molecule compounds. The article was posted on the PHARMA JAPAN website.
Read the full article in PHARMA JAPAN here.
PHARMA JAPAN Posted on August 7, 2020
[LICENSE NO. 20200818_01] Jiho Inc. permits the use of articles.
Axcelead has been selected as one of the “Top 10 Drug. Discovery Consulting / Services Companies in APAC 2019,”
In September 2019, Axcelead Drug Discovery Partners has been recognized by Pharma Tech Outlook Magazine as Top 10 Drug Discovery & Development Consulting / Services Companies in APAC.
Read the full article in Pharma Tech Outlook Magazine here.
|2021.01.25||Dr.Kawamoto and Dr.Tanaka will give a lecture at the iForum ™ 2021 Virtual User Group Meeting on January 28th.|
|2021.01.08||Axcelead's response to the COVID-19 emergency declaration in January 2021|
|2020.12.10||Evommune and Axcelead Drug Discovery Partners Launch A Collaboration On A PKCtheta Program To Kick-off Evommune’s Inflammation Pipeline|
|2020.10.02||Axcelead and Kyowa Kirin Started an Innovative Collaboration in Small-Molecule Drug Development|
|2020.09.23||Dr. Yoshinori Ikeura will give a lecture at RSC Medicinal Chemistry Desktop Seminar Series on October 14th|